Objective: To identify factors associated with in-hospital mortality in neonates and children undergoing continuous electroencephalography (cEEG) monitoring in the intensive care unit (ICU). Methods: We performed a retrospective observational study in patients from birth to 21 years of age who underwent clinically indicated cEEG in the ICU from 2011 to 2013. The main outcome measure was in-hospital mortality. Results: Six-hundred and twenty-five patients (54.2% male) met eligibility criteria, of whom 211 were neonates (55% male, 24.8% premature) and 414 were pediatric patients (53.9% male). Electrographic seizures occurred in 176 patients (28.2%) and status epilepticus (SE) occurred in 20 (11.4%). The time from ICU admission to cEEG initiation was 16.7 (5.1-94.4) h. Eighty-nine patients (14.2%) (30 [14.2%] neonates, and 59 [14.3%] pediatric patients) died in the hospital. In neonates-after controlling for gender and prematurity-independent factors associated with mortality were prematurity (odds ratio [OR] 2.63. 95% confidence interval [CI] 1.06-6.5, p = 0.037), presence of status epilepticus (SE); OR 8.82, 95% CI 1.74-44.57, p = 0.008), and time from ICU admission to initiation of cEEG (OR 1.002, 95% CI 1.001-1.004 per hour, p = 0.008]. In pediatric patients-after controlling for gender and age-independent factors associated with mortality were the absence of seizures factors associated with mortality were absence of seizures (OR = 4.3, (95% CI: 1.5-12.4), p = 0.007), the presence of SE (OR 7.76, p = 0.016), and the time from ICU admission to initiation of cEEG (OR 1.001, 95% CI 1.0002-1.001, per hour, p = 0.005]. Significance: Both presence of electrographic SE and time from ICU admission to cEEG initiation were independent factors associated with mortality in neonates and pediatric patients with cEEG in the ICU.
Electrographic seizures are common in the pediatric intensive care unit (ICU) affecting 10-50% of patients undergoing clinically indicated continuous electroencephalography (cEEG) monitoring. 1, 2 Around one third of these electrographic seizures are exclusively subclinical and would go undetected without the use of EEG. 1 The incidence of seizures is higher during the neonatal period than in any other time of life. 3 In addition, the great majority of neonatal seizures are either clinically subtle or clinically undetectable. 3, 4 The EEG background provides insight into global neurologic function in patients in whom the physical examination is limited due to sedation or because of the intrinsic limitations of neonatal examination. The use of cEEG monitoring in the ICU is growing exponentially at a pace of approximately 30% per year both in adults 5 and children, 6 and current guidelines emphasize the importance of cEEG as the gold standard for diagnosing paroxysmal events in the neonatal ICU. 7 Electrographic seizures and electrographic status epilepticus (SE) are independently associated with outcome in neonates, [8] [9] [10] [11] children, 1,2,9,10,12,13 and adults. 14, 15 This association is not necessarily causal; the extent to which electrographic seizures produce secondary brain injury-as compared with simply representing a biomarker of more severe acute brain injury-remains unknown. 16 The association between seizure duration and outcome may be confounded by several factors. Potential confounders such as age and underlying etiology are usually controlled for; however, the time from the onset of the acute condition to cEEG monitoring is rarely controlled for or even evaluated as a potential confounder or potential outcome predictor. A series of 49 adults evaluating delay in cEEG as a potential predictor of outcome 15 showed that for every hour delay in diagnosis of electrographic seizures, the odds ratio for mortality increased by 0.131, or 13%. 15 The time to detection and treatment of seizure may be important. A recent series showed that early seizure detection and treatment is associated with a higher likelihood of seizure termination. 17 Surprisingly, there are no other series evaluating time to cEEG as a potential predictor of outcome.
This study aims to address this gap in knowledge by describing the factors associated with in-hospital mortality in neonates and children undergoing cEEG in the ICU, including delay to initiation of cEEG monitoring.
Patients and Methods

Standard protocol approvals, registrations, and patient consent
This study was approved by the Boston Children's Hospital Institutional Review Board.
Study design
This was a retrospective descriptive study conducted at Boston Children's Hospital, a tertiary-care pediatric hospital. The purpose of this study was to evaluate the factors associated with short-term mortality both in neonates and children who underwent a clinically indicated cEEG in the ICU.
Patients
There are several intensive care settings in our center: (1) the neonatal ICU, which admits patients with age at admission from birth to younger than 6 months of age; (2) the cardiac ICU, which admits patients with age at admission from birth to adults; (3) the medical and surgical ICU, which admits patients with age at admission from birth to adults; and (4) the medical ICU, which admits patients with age at admission from younger than 1 month of age to adults. We did not include patients from the semi-intensive care program units. At our institution, a neuroICU consult team covering all pediatric and neonatal ICUs and an epilepsy team including epileptologists and EEG technologists are immediately available at all times. All ICU patients with a primary or secondary neurologic condition are evaluated by the neuroICU team. The neuroICU team based on clinical judgement suggests the need for a cEEG to the epilepsy team, the cEEG gets started as soon as possible, and the initial EEG tracing is read within 1 h by the epilepsy team. Subsequent EEG reads occur approximately every 8 h, or more frequently if deemed necessary by the findings on the initial or subsequent EEG readings. The neuroICU team sometimes evaluates the patient before deciding on the need for EEG, but if the clinical history suggests that the patient will need cEEG-like in the case of moderate to severe neonatal hypoxic-ischemic encephalopathy-the cEEG is started before evaluating the patient. At our institution, seizures (both electroclinical and electrographic only) detected first on cEEG are actively treated except in patients with poor prognosis in whom redirection of care to comfort-only measures is the goal.
Inclusion criteria were the following: (1) age from birth-including premature babies-to 21 years, (2) cEEG monitoring in one of the ICU settings (neonatal ICU, cardiac ICU, medical and surgical ICU, and medical ICU) at Boston Children's Hospital, and (3) ICU admission between January 1st, 2011 and December 31st, 2013. Exclusion criteria were cEEG in a non-ICU setting or cEEG in the ICU during a scheduled ICU admission or epilepsy surgery. cEEG initiated in other setting but continued in the ICU were included in the analysis. Critically ill newborns present with etiologies, evolutions, and outcomes different from those of older critical pediatric patients. Data were analyzed separately for newborns and pediatric patients. Newborns were defined as patients with an age of <28 days of life normalized to 40 weeks of gestational age, regardless of gestational age at birth and regardless of specific ICU of admission. We considered prematurity as birth before 37 weeks of gestational age.
EEG data
EEG studies were performed using the international standard 10-20 system of electrode placement for both pediatric patients and newborns. We considered an EEG to be a cEEG when it was recorded uninterruptedly for at least 3 h, following the threshold initially proposed by the Pediatric Critical Care EEG group. 6 When there were several ICU admissions with cEEG for the same patient during the study period, only the first one was considered. Electrographic
Key Points
• Critically ill neonates and children are frequently monitored with cEEG
• We retrospectively studied factors associated with inhospital mortality in 625 patients, 211 neonates, and 414 pediatric patients
• Independent factors associated with mortality in neonates were prematurity, presence of status epilepticus, and time to initiation of cEEG • Independent factors in pediatric patients were the absence of seizures, the presence of status epilepticus, and time to initiation of cEEG seizures were defined as abnormal, paroxysmal EEG events that differed from the background activity, lasted longer than 10 s (unless associated with clinical signs, in which case they were considered seizures regardless of duration), and evolved in frequency, morphology, and spatial distribution. 18 For the purposes of this study, we considered electrographic seizures as any seizure detected on EEG, which could be electroclinical (with a clinical correlate) or electrographic-only (exclusively subclinical). 18 Electrographic SE was defined as a continuous electrographic seizure lasting at least 30 min, or recurrent electrographic seizures totaling >50% of any 1-h epoch. 18 All EEG studies were interpreted for clinical care and the information extracted from the clinically-generated EEG reports.
Variables
The main outcome measure was in-hospital mortality. We collected information on factors associated with this outcome including the following: (1) age, (2) gender, (3) gestational age (only for newborns), (4) etiology, (5) presence of electrographic seizures or electrographic SE during cEEG monitoring, (6) time from ICU admission to start of cEEG monitoring, and (7) time from ICU admission to first detected seizure. Etiologies were classified as follows: (1) structural if in the presence of a clinically relevant magnetic resonance imaging (MRI) abnormality including hypoxic injury and ischemic or hemorrhagic infarction; (2) nonstructural if there was no focal abnormality on MRI but there was suspicion of genetic, metabolic, or infectious etiologies; and (3) non-central nervous system (CNS) indicating critical illness secondary to a system outside the central nervous system (e.g., cardiac). Study data were collected and managed using REDCap electronic data capture tools hosted at Boston Children's Hospital. REDCap (Research Electronic Data Capture) is a secure, web-based application designed to support data capture for research studies. 19 
Statistical analysis
Demographic and clinical characteristics were summarized with descriptive statistics. On univariate analysis, we evaluated the association between the primary outcomemortality, a dichotomous outcome-and different factors associated with outcome, with simple logistic regression for continuous variables and with Fisher's exact test for categorical variables. In multivariable analysis, a complete case analysis logistic regression was performed: the outcome was in-hospital mortality, and the predictors were age, gender, prematurity (only for newborns), presence of electrographic seizures, presence of electrographic SE, and time from ICU admission to cEEG initiation. We considered prematurity as birth before 37 weeks of gestational age. Statistical significance was set at a conventional two-sided alpha value of 0.05. All statistical analyses were performed with STATA 12 (Stata Corp., College Station, TX, U.S.A.).
Results
Demographic and clinical features
Six-hundred twenty-five patients (54.2% male) met eligibility criteria. Median (p 25 -p 75 ) age was 0.75 (0.03-7.58) years. There were 211 newborns (55.0% male) who had a postnatal age of 3.95 (0.9-13.1) days and 414 pediatric patients (53.9% male) who had an age of 4.17 (0.8-11.3) years. The time from ICU admission to cEEG initiation was 16.7 (5.1-94.4) h, 15.1 (4.9-104.8) h in newborns, and 17.8 (5.1-91.4) h in pediatric patients (Fig. 1) . Eightynine patients (14.2%) died in-hospital, of which 30 (14.2%) were newborns, and 59 (14.3%) were pediatric patients. Details on the main demographic and clinical features can be found in Table 1 .
Univariate analysis
On univariate analysis, the presence of electrographic SE and the time elapsed from ICU admission to cEEG initiation were associated with increased mortality. Other factors associated with mortality were prematurity (only in newborns) and lack of seizures (only in pediatric patients). Age, gender, etiology, presence of an acute trigger (when present), and time from ICU admission to first detected seizure were not associated with increased mortality (Table 2) .
Multivariate analysis
In newborns-after controlling for gender and prematurity-factors associated with mortality were prematurity (odds ratio [OR] 2.63, 95% confidence interval [CI] 1.06-6.5, p = 0.037), presence of SE (OR 8.82, 95% CI Figure 1 . Time from ICU admission to cEEG monitoring in hours. Data for newborns appear in green and data for pediatric patients appear in dark red. For clarity, the x axis is arbitrarily truncated at 72 h. cEEG, continuous electroencephalography; ICU, intensive care unit. Epilepsia ILAE 1.74-44.57, p = 0.008), and time from ICU admission to initiation of cEEG (OR 1.002, 95% CI 1.001-1.004 or 0.2%, 95% CI 0.1-0.4%)/h, p = 0.008), but gender and presence of seizures were not associated with mortality (Table 3 ). In pediatric patients-after controlling for gender and age-factors associated with mortality were absence of seizures (OR 4.3, 95% CI 1.5-12.4, p = 0.007), presence of SE (OR 7.76, 95% CI 1.47-40.91, p = 0.016), and time from ICU admission to initiation of cEEG (OR 1.001, 95% CI 1.0002-1.001 or 0.1%, 95% CI 0.02-0.1%/h, p = 0.005). Age and gender were not associated with mortality (Table 4) . When adding etiology as a categorical variable with four categories (symptomatic structural, symptomatic nonstructural, unknown, and non-CNS) or as presence or absence of an acute trigger to the logistic regression model, etiology remained nonsignificantly associated with mortality, and the results did not vary substantially (Tables S1-S4 ).
cEEG and seizures that started before ICU admission Fifty patients (16 newborns and 34 pediatric patients) started on cEEG before ICU admission, and 13 patients (6 newborns and 7 pediatric patients) had their first seizure before ICU admission. Considering only the 575 patients (195 newborns and 380 pediatric patients) who started cEEG recordings after ICU admission, the results on the prediction value of time to cEEG did not change (Tables S5 and S6 ).
Discussion
In this single-center study we looked at the impact of several clinical and EEG variables on in-hospital mortality. Our main findings are that in critically ill neonates and children on clinically indicated cEEG, the time from ICU admission to cEEG initiation and the presence of electrographic SE are independently associated with increased inhospital mortality.
Factors associated with outcome for critical patients in the ICU help identify those patients at higher risk for cognitive sequelae and mortality. [20] [21] [22] Although factors such as age and-in most cases etiology-are not amenable to intervention, other factors such as time to recognition and treatment are potentially modifiable and may impact other factors such as electrographic seizure duration. [20] [21] [22] There is an association between electrographic seizure burden on cEEG and worse outcomes in terms of morbidity and mortality for neonates, [8] [9] [10] [11] pediatric patients, 1,2,9,10,12,13 and adults. 14, 15 However, this association is not necessarily causal. Electrographic seizure burden can contribute independently to worse outcomes. However, it is also possible that electrographic seizure duration simply represents a biomarker of a more severe underlying etiology, which may not improve with treatment. 4 Furthermore, although the abovementioned studies corrected for potential confounders in the The time from onset of the critical condition to EEG evaluation might influence prognosis in two ways. First, it might confound the relationship between electrographic seizures and outcome, as electrographic seizures may be accruing prior to EEG initiation and represent an additional unrecognized seizure burden. Second, time to diagnosis of an EEG abnormality might be in itself an outcome predictor because delayed diagnoses might imply delayed treatment. The literature has focused preferentially on seizure burden with little attention to time to diagnosis and intervention. In a series of 49 critically ill adults with cEEG monitoring, the only factors independently associated with mortality were seizure duration (OR 1.131 per hour) and delay to diagnosis (OR 1.039 per hour). 15 The mortality was 36% when patients were evaluated by EEG and diagnosed with nonconvulsive seizures within 30 min of onset, 39% when this occurred 1-24 h after onset, and 75% in those with diagnosis later than 24 h. 15 In a study on the impact of a standardized EEG monitoring pathway in critically ill children, 41 patients admitted before pathway implementation were compared with 21 similar patients after the implementation of the pathway. 17 The median (p 25 -p 75 ) interval from seizure onset to administration of antiepileptic drugs was shorter in patients treated after the implementation of the pathway (64 [50-101] vs. 17 Furthermore, the interval from seizure onset to antiepileptic drug order was also shorter in the patients on the pathway (31 vs. 71 [33-131] min). 17 It is notable that seizure termination occurred more frequently following initial antiepileptic drug administration in patients on the EEG monitoring pathway (67% vs. 27%).
17 Surprisingly, there are no other series that have evaluated the relationship between the time elapsed from onset of the acute condition to cEEG initiation.
Our series addresses this gap in knowledge by evaluating the factors associated with in-hospital mortality, including the time from onset of the critical condition to cEEG initiation. Both in newborns and pediatric patients, seizure burden (represented by the presence of electrographic SE), and time from ICU admission to cEEG monitoring initiation were independent factors associated with mortality. Prematurity was an additional independent factor associated with mortality in newborns with an OR of 2.63. However, the presence of electrographic SE was a stronger factor associated with mortality with an OR of 8.82. In newborns, for each hour delay from ICU admission to cEEG initiation, the mortality OR increased by 0.002. Although this increase might not seem particularly relevant, it means that for each day of delay since ICU admission to cEEG initiation, the mortality OR increased by 0.055 or 5.5%. In older pediatric patients, the lack of seizures was a factor associated with mortality with an OR of 4.3. Although this may appear counterintuitive, it might reflect the inability of severely damaged brains to generate seizures. In older pediatric patients, the presence of electrographic SE increased the mortality OR by 7.76, and for delay since ICU admission to cEEG initiation, the mortality OR increased by 0.001 per hour or by 0.019 (1.9%) per day. Our data indicate that time from ICU admission to initiation of cEEG monitoring is an independent factor associated with short-term mortality, both in newborns and older pediatric patients.
The association between time to cEEG and in-hospital mortality provides an additional potentially modifiable risk factor for critical children in the ICU and also gives insight into the association between electrographic SE and mortality. A growing body of literature suggests that electrographic seizures are not only a biomarker of more severe brain injury, but they probably independently contribute to physiologic changes, secondary brain injury, and worse outcomes. 18 Our series shows that the time to cEEG influences short-term mortality, further supporting the hypothesis that seizure burden is an independent factor in outcome. 2, 18 In addition, our results suggest that timely identification of electrographic seizures and electrographic SE might not only modify management and potentially decrease electrographic seizure burden, 23 but also might be associated with better objective outcomes.
Strengths and weaknesses
The time from ICU admission to cEEG initiation is a surrogate variable. The interval from the onset of the critical illness to the time of first detected electrographic seizure, although perhaps unmeasurable if not undocumentable, may be the ideal variable. The time to first detected electrographic seizure could be evaluated only in patients who had electrographic seizures, who represent approximately 20-30% of our study population. In this subpopulation with electrographic seizures we noted 19 deaths, and the relatively low proportion of death within our cohort likely accounts for lack of a significant association between time to first seizure and in-hospital mortality. However, our data represent an attempt to evaluate the importance of timely cEEG initiation in the ICU, and to tentatively establish this identifiable measure as a potential quality indicator. Our patient population is not necessarily representative of all critically ill children in the ICU or of all children with cEEG in an ICU. Our retrospective analysis may be affected by confounding by indication: the decision of whether and when to start cEEG was not random, but based on the clinical judgment of the medical team. It can be argued that cEEG was started later in patients whose conditions were more severe at the beginning and could not initially tolerate cEEG or required more immediate life-saving procedures; under that assumption delay of cEEG could potentially be a surrogate marker for disease severity. Only prospective studies that randomize patients to receiving or not receiving cEEG in the ICU may help resolve this dilemma. The best next approach to a randomized prospective study is to perform a multivariable regression controlling for potential confounders (or surrogate markers of severity). In our multivariable regression model, we controlled for prematurity (only for newborns), presence of electrographic seizures, and presence of electrographic SE. Because etiology can be a potential confounder of outcome, we performed a multivariable analysis with etiology among the potential confounders (Table S1 -S4): time from ICU admission to start of cEEG remained highly significant in both pediatric and neonatal patients. Even if results do not have the same level of evidence as a prospective randomized study, our study suggests an effect of time to cEEG after controlling for different markers of severity. We have no data on what causes delays in the time to start cEEG. Future prospective studies of our research group plan to assess the presumed causes of delay such as different availability of technologists at different hours during the day, different degree of clinical suspicion for seizures, or need for more urgent procedures before cEEG or severe patient instability. Our facility is a large academic referral center, potentially limiting the generalizability of results. A population large enough to evaluate factors associated with mortality can only be recruited in large centers or in multicenter studies, but there is no reason to believe that factors associated with mortality in our series would be different in smaller centers. A related challenge to generalizability is that patients who undergo cEEG are not a random sample of all patients in the ICU, but probably represent a subpopulation more prone to electrographic seizures. Due to logistical and ethical issues, few data are available regarding the yield of cEEG on patients in the ICU with no clinical suspicion of seizures. In a series of 69 adults with nontraumatic subarachnoid hemorrhage, the first 17 patients underwent cEEG for clinical suspicion of electrographic seizures, but the following 52 patients underwent cEEG as part of a protocol regardless of clinical suspicion. 24 In patients with clinical suspicion, electrographic seizures occurred in 17.7%, whereas in the patients on cEEG per protocol, electrographic seizures occurred in 9.6%; furthermore, among the 35 patients monitored per protocol and without a clinical suspicion for seizures, electrographic seizures occurred in only 8.6%. 24 These results suggest that the incidence of seizures is higher in patients in whom cEEG is placed for a clinical suspicion of electrographic seizures. Our sample is not representative of all patients in the ICU, and our results are generalizable to patients who have a clinically indicated cEEG in the ICU. It is reasonable to assume that the frequency of seizures is lower in patients in the ICU who do not undergo cEEG, but only prospective randomized studies will provide a more reliable estimate for these patients.
We divided our study population into two groups: newborns and pediatric patients. Although it would have been interesting to stratify newborns by degree of prematurity the relative low number of premature babies in this series did not allow such subgroup analysis. In our series, etiology was not associated with in-hospital mortality in the univariate or multivariate analysis. This lack of association remained for etiology in a four-item classification: symptomatic structural, symptomatic nonstructural, unknown, and non-CNS etiology; as well as for a two-item classification: presence or absence of an acute trigger. Although this might seem counterintuitive, several series of neonatal, pediatric, and adult patients with cEEG in the ICU did not find an independent association of etiology with outcome. 11, 13, 15 One of the major factors that determines the presence of electrographic seizures is the a priori severity of illness or the degree of clinical suspicion for seizures. Unfortunately, we had no way to determine the severity of illness or the degree of clinical suspicion in the retrospective data analysis.
Our series evaluated an easy to quantify and crude outcome such as in-hospital mortality. There is limited literature on more subtle outcomes, such as cognitive function. A series of 137 children with normal neurodevelopment prior to an acute neurologic condition with admission to the ICU suggests that seizure burden worsens neurobehavioral outcome. 25 Our results set the stage to include time to cEEG initiation as a factor associated with mortality and a potential predictor of other outcomes, for example, cognitive or neurologic functioning in future studies. Furthermore, our findings suggest that early monitoring may improve outcomes. Current literature not only shows good cost-effective profile for cEEG in the ICU, but also potential for improved outcomes at lower costs. 26, 27 Major strengths of our series include a large patient population, as well as finding of an independent association between timely utilization of cEEG and better outcome.
Future directions
Much emphasis has been placed on the need to treat electroclinical and electrographic-only seizures to decrease seizure burden. 2, 10 However, little attention has been paid to how the timing of treatment affects outcome. 15 In pediatric convulsive SE, marked delays in treatment administration are common. 28 To date, timing is not studied as a determinant factor of outcome in most studies of seizures and SE in the ICU.
1,2,8-14 Our results set the stage for future multicenter prospective studies in which time to seizure detection and time to treatment are evaluated in detail as one of the potential predictors of mortality in patients with cEEG in the ICU.
Conclusion
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